© 1991 Oxford University Press
research-article |
Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,643 to clofibric acid, nafenopin and LY171883
Toxicology Divison, Lilly Research Laboratories, Eli Lilly and Company Greenfield, IN 46140, USA
The mitogenic effects of peroxisome proliferating agents have been implicated in their carcinogenicity. WY-14,643 stimulates an increase in hepatocellular DNA replication that persists with continued administration, but it is unclear if other peroxisome proliferators share this property. In these Studies, WY-14,643 was compared to clofibric acid, nafenopin and LY171883 given to rats in the diet for up to 30 days. DNA replication in the rat liver was quantified by immunohistochemical methods after continuous s.c. infusion of bromodeoxyuridine by osmotic minipump. During the first 7 days of treatment, WY-14,643 (0.1% in diet) and nafenopin (0.05%) increased the percentage of bromodeoxyuridinelabeled hepatocytes to > 50%, from 3% in controls. Clofibric acid (0.5%) and LY171883 (0.3%) increased the labeling to {small tilde}33%. The replicative response to each of the compounds was localized primarily to the periportal region of the liver lobule. The time-course of replication induced by clofibric acid and WY-14,643 was examined over 3 day intervals. The peak of replication in response to clofibric acid occurred during days 4–6, whereas the effect of WY-14,643 peaked during days 1–3 and was much greater than clofibric acid. The replicative response to WY-14,643 persisted through 30 days at dietary concentratioas of 0.1 and 0.005%. Nafenopin, LY171883 and clofibric acid were without effect on DNA replication on days 28-30 even though the hepatomegaly and induction of peroxisomal ßoxidation persisted. Thus, under the conditions of these experiments, the persistent replicative effect through 30 days was unique to WY-14,643. Although sustained replication in the general population of hepatocytes may be involved in the carcinogenesis of WY-14,643, it does not appear to be a factor in the hepatocarcinogenesis of the other peroxisome proliferators.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. P. Glauert, A. Eyigor, J. C. Tharappel, S. Cooper, E. Y. Lee, and B. T. Spear Inhibition of Hepatocarcinogenesis by the Deletion of the p50 Subunit of NF-{kappa}B in Mice Administered the Peroxisome Proliferator Wy-14,643 Toxicol. Sci., April 1, 2006; 90(2): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Burkhardt, R. Bahnemann, K. Failing, and M. Reinacher Zonal Distribution of Cell Proliferation in the Liver of Untreated B6C3F1 and C57BL Mice Toxicol Pathol, January 1, 2004; 32(1): 100 - 105. [Abstract] [PDF]
|
|
|
|
|
|
J. C. Tharappel, A. Nalca, A. B. Owens, L. Ghabrial, E. C. Konz, H. P. Glauert, and B. T. Spear Cell Proliferation and Apoptosis Are Altered in Mice Deficient in the NF-{kappa}B p50 Subunit after Treatment with the Peroxisome Proliferator Ciprofibrate Toxicol. Sci., October 1, 2003; 75(2): 300 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. O'Brien, M. L. Cunningham, B. T. Spear, and H. P. Glauert Peroxisome Proliferators Do Not Activate the Transcription Factors AP-1, Early Growth Response-1, or Heat Shock Factors 1 and 2 in Rats or Hamsters Toxicol. Sci., September 1, 2002; 69(1): 139 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Tharappel, M. L. Cunningham, B. T. Spear, and H. P. Glauert Differential Activation of Hepatic NF-{{kappa}}B in Rats and Hamsters by the Peroxisome Proliferators Wy-14,643, Gemfibrozil, and Dibutyl Phthalate Toxicol. Sci., July 1, 2001; 62(1): 20 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kono, M. Nakagami, I. Rusyn, H. D. Connor, B. Stefanovic, D. A. Brenner, R. P. Mason, G. E. Arteel, and R. G. Thurman Development of an animal model of chronic alcohol-induced pancreatitis in the rat Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1178 - G1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brennan, E. M. Boncavage-Hennessey, M. J. Wolfe, M. W. Toussaint, W. E. Dennis, A. B. Rosencrance, and H. S. Gardner JR An In Vivo Method for Using 5-Bromo-2'-deoxyuridine (BrdU) as a Marker of Chemically-Induced Hepatocellular Proliferation in the Japanese Medaka (Oryzias latipes) Toxicol Pathol, April 1, 2001; 29(3): 387 - 397. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Isenberg, L. M. Kamendulis, J. H. Smith, D. C. Ackley, G. Pugh Jr., A. W. Lington, and J. E. Klaunig Effects of Di-2-Ethylhexyl Phthalate (DEHP) on Gap-Junctional Intercellular Communication (GJIC), DNA Synthesis, and Peroxisomal Beta Oxidation (PBOX) in Rat, Mouse, and Hamster Liver Toxicol. Sci., July 1, 2000; 56(1): 73 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Ledda-Columbano, A. Perra, R. Loi, H. Shinozuka, and A. Columbano Cell Proliferation Induced by Triiodothyronine in Rat Liver Is Associated with Nodule Regression and Reduction of Hepatocellular Carcinomas Cancer Res., February 1, 2000; 60(3): 603 - 609. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. L. Rose, R. C. Cattley, C. Dunn, V. Wong, X. Li, and R. G. Thurman Dietary glycine prevents the development of liver tumors caused by the peroxisome proliferator WY-14,643 Carcinogenesis, November 1, 1999; 20(11): 2075 - 2081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Rose, C. A. Rivera, B. U. Bradford, L. M. Graves, R. C. Cattley, R. Schoonhoven, J. A. Swenberg, and R. G. Thurman Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators Carcinogenesis, January 1, 1999; 20(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Lalwani, L. A. Dethloff, J. R. Haskins, D. G. Robertson, and F. A. De La Iglesia Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver Toxicol Pathol, March 1, 1997; 25(2): 165 - 176. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117. [PDF]
|
|
|
|
|
|
A. M. Bendele, J. F. Hulman, S. White, C. Brodhecker, and R. A. Bendele Hepatocellular Proliferation in Ibuprofen-Treated Mice Toxicol Pathol, January 1, 1993; 21(1): 15 - 20. [Abstract] [PDF]
|
|